ASHLEY MCCAMMON: Open Payments
NPI 1093303885 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 69 payments from 21 companies in 2025. Trend: 2023 $2,973 · 2024 $2,007 · 2025 $1,435
Food & beverage: $1,388Education: $47
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $323 |
| GlaxoSmithKline, LLC. | 18 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $116 |
| GENZYME CORPORATION | 4 | $97 |
| Verona Pharma, Inc. | 5 | $92 |
| HARMONY BIOSCIENCES LLC | 2 | $87 |
| JAZZ PHARMACEUTICALS INC. | 2 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Inspire Medical Systems, Inc. | 2 | $48 |
Products named: AIRSUPRA, DUPIXENT, TRELEGY ELLIPTA, Ohtuvayre, XYWAV, OFEV, NUCALA, Sunosi.
Industry payments across IN — which companies pay providers there.
